Key result
4-aminopyridine blocks the cloned mouse Kv1.1 channel intracellularly in its cationic form, with an IC50 of 147 microM extracellularly and 117 microM intracellularly.
This preclinical study demonstrates that 4-aminopyridine crosses the cell membrane in its uncharged form and blocks the mKv1.1 potassium channel intracellularly in its cationic form.
Answers are grounded in this paper and cite their sources.
Caution against clinical extrapolation from this mouse model; leaves open mechanistic validation in human cardiac Kv channels.
This study used the whole-cell patch clamp technique to investigate the mechanism of action of the K+ channel blocker 4-aminopyridine (4-AP) on the cloned K+ channel mouse Kv1.1 (mKv1.1) expressed in Chinese hamster ovary cells. 2. Cells transfected with mKv1.1 expressed a non-inactivating, delayed rectifier-type K+ current. 4-AP induced a dose-, voltage- and use-dependent block of mKv1.1. 3. 4-AP blockade of mKv1.1 was similar whether 4-AP was administered extracellularly (IC50 = 147 microM) or intracellularly (IC50 = 117 microM). 4. Inclusion of the first twenty amino acids of the N-terminus sequence of the Shaker B K+ channel ('inactivation peptide') in the patch electrode transformed mKv1.1 into a rapidly inactivating current. The time constant of decay for the modified current was dependent on the concentration of inactivation peptide, and under these conditions extracellular 4-AP had a reduced potency (IC50 values of 471 and 537 microM for 0.5 and 2 mg ml-1 inactivation peptide, respectively). 5. A permanently charged analogue of 4-AP, 4-aminopyridine methiodide (4-APMI), was found to block mKv1.1 when applied inside the cell, but was without effect when administered externally. 6. Decreasing the intracellular pH (pHi) to 6.4 caused an increase in 4-AP potency (IC50 = 76 microM), whereas at pHi 9.0, the 4-AP potency fell (IC50 = 295 microM). Conversely, increasing extracellular pH (pHo) to 9.0 caused an increase in 4-AP potency (IC50 = 93 microM), whereas at pHo 6.4, 4-AP potency decreased (IC50 = 398 microM). 7. Taken together, these findings support the hypotheses that the uncharged form of 4-AP crosses the membrane, and that it is predominantly the cationic form which acts on mKv1.1 channels intracellularly, possibly at or near to the binding site for the inactivation peptide.
No takes yet. Share an insight, caveat, or question.
Stephens et al. (1994) studied this question. 4-aminopyridine (4-AP) was evaluated on IC50 of 4-AP blockade. 4-aminopyridine blocks the cloned mouse Kv1.1 channel intracellularly in its cationic form, with an IC50 of 147 microM extracellularly and 117 microM intracellularly.
Synapse has enriched 10 related papers. Consider them for comparative context: